Byhealth Gestione

Gestione criteri di controllo 3/4

Byhealth Il CEO è Zhicheng Lin, nominato in Sep2014, ha un mandato di 10.17 anni. possiede direttamente 0.021% delle azioni della società, per un valore di CN¥ 4.51M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 10.2 anni e 5.4 anni.

Informazioni chiave

Zhicheng Lin

Amministratore delegato

CN¥7.0m

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	10.2yrs
Proprietà del CEO	0.02%
Durata media del management	10.2yrs
Durata media del Consiglio di amministrazione	5.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Zhicheng Lin (56 yo)

10.2yrs

Mandato

CN¥7,000,300

Compensazione

Mr. Zhicheng Lin has been Chief Executive Officer at Byhealth Co.,Ltd since September 26, 2014 and served as its Vice President and Secretary since June 2012 and since July 2012 respectively. Mr. Lin was D...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Zhicheng Lin	CEO & Non-Independent Director	10.2yrs	CN¥7.00m	0.021% CN¥ 4.5m
Jinyin Tang	Secretary to the Board of Directors	6.6yrs	CN¥1.04m	Nessun dato
Hong Chen	Deputy General Manager	16.2yrs	CN¥5.00m	1.05% CN¥ 229.2m
Liangping Cai	Deputy General Manager	10.2yrs	CN¥5.00m	0.032% CN¥ 6.9m

10.2yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di 300146 è esperto e expertise (durata media dell'incarico 10.2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Zhicheng Lin	CEO & Non-Independent Director	10.2yrs	CN¥7.00m	0.021% CN¥ 4.5m
Shuisheng Liang	Non-Independent Vice Chairman	16.2yrs	CN¥5.00m	1.02% CN¥ 222.3m
Yunchao Liang	Non-Independent Chairman of the Board	16.2yrs	CN¥604.40k	42.17% CN¥ 9.2b
Yu Ming Hu	Independent Director	1.3yrs	CN¥42.60k	Nessun dato
Hui Tang	Non-Independent Director	16.2yrs	CN¥8.26m	0.43% CN¥ 92.8m
Heng Liu	Independent Director	1.3yrs	CN¥42.60k	Nessun dato
Zhuoyi Wu	Chairman of the Supervisory Board	1.3yrs	CN¥1.80m	Nessun dato
Huizhen Shi	Member of Supervisory Board	6.7yrs	Nessun dato	Nessun dato
Chuanyuan Deng	Independent Director	4.2yrs	CN¥120.00k	Nessun dato
Le Li	Supervisor	2.8yrs	Nessun dato	Nessun dato

5.4yrs

Durata media

56yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 300146 sono considerati esperti (durata media dell'incarico 5.4 anni).

Byhealth Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Byhealth Co., Ltd, Annual General Meeting, Apr 11, 2024

High number of new directors

Byhealth Co. Ltd. Approves Executive Appointments

By-health Co., Ltd., Annual General Meeting, Mar 26, 2021

By-health Co., Ltd. Announces Management Appointment

Recent updates

Third quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.21 profit in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Byhealth Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

New minor risk - Earnings quality

Second quarter 2024 earnings released: EPS: CN¥0.095 (vs CN¥0.30 in 2Q 2023)

Byhealth Co., Ltd to Report First Half, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: CN¥0.43 (vs CN¥0.61 in 1Q 2023)

Dividend increased to CN¥0.90

Byhealth Co., Ltd Approves Cash Dividend for the Year 2023

Byhealth Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

Byhealth Co., Ltd Announces Profit Distribution Proposal for 2023

Byhealth Co., Ltd, Annual General Meeting, Apr 11, 2024

Full year 2023 earnings released: EPS: CN¥1.03 (vs CN¥0.82 in FY 2022)

Now 21% overvalued

Byhealth Co., Ltd to Report Fiscal Year 2023 Results on Mar 19, 2024

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.25 in 3Q 2022)

Provexis plc Announces Byhealth Co., Ltd Regulatory Filing with Chinese SAMR

High number of new directors

Byhealth Co. Ltd. Approves Executive Appointments

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.23 in 2Q 2022)

Byhealth Co., Ltd to Report First Half, 2023 Results on Aug 05, 2023

Full year 2022 earnings released: EPS: CN¥0.82 (vs CN¥1.06 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.17 in 3Q 2021)

Second quarter 2022 earnings released

First quarter 2022 earnings released: EPS: CN¥0.39 (vs CN¥0.52 in 1Q 2021)

By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022

By-Health Co., Ltd. Approves Cash Dividend for 2021

By-health Co., Ltd. Proposes Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.32 in 3Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.52 (vs CN¥0.34 in 1Q 2020)

Investor sentiment improved over the past week

By-health Co., Ltd., Annual General Meeting, Mar 26, 2021

New 90-day high: CN¥28.08

Full year 2020 earnings released: EPS CN¥0.96 (vs CN¥0.24 loss in FY 2019)

Revenue misses expectations

New 90-day low: CN¥22.89

By-health Co., Ltd. to Report Fiscal Year 2020 Results on Mar 06, 2021

New 90-day high: CN¥25.87

Third quarter earnings released

By-health Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

By-health Co., Ltd. Announces Management Appointment

New 90-day high - CN¥23.69

By-health Co., Ltd. to Report First Half, 2020 Results on Jul 30, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media